27.09.2018 • NewsElaine BurridgeIneoskoch

Ineos Takes Intermediates from Flint Hills

Ineos Takes Intermediates from Flint Hills (c) Ineos
Ineos Takes Intermediates from Flint Hills (c) Ineos

Ineos Enterprises has entered  into a binding agreement to buy the chemical intermediates business of Flint Hills Resources, a wholly owned subsidiary of Koch Industries, said to be one of the largest privately owned companies in the US. Financial terms were not disclosed.

The business comprises facilities located near Chicago, Illinois, for producing isophthalic acid (PIA), trimellitic anhydride (TMA) and maleic anhydride (MAN).  The intermediates made at the site are distributed worldwide and used in a diverse range of end-use applications such as coatings, clothing, paints and gasoline additives.

Flint Hills also has offices and distribution operations at various locations in the US, Europe and Asia. Its workforce of around 260 people will transfer to Ineos Enterprises following completion of the deal, which is expected by the end of 2018, subject to regulatory approval.

Ashley Reed, CEO of Ineos Enterprises, said the chemicals intermediates business fits well with Ineos’s portfolio, adding that the UK-based group has a track record of acquiring businesses that are no longer core to their previous owners.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.